Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $280.27 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $181.55 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $20.96 | 1 | $0 (2019) |
| ABBVIE INC. | $17.80 | 1 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $17.39 | 1 | $0 (2024) |
| Novo Nordisk Inc | $17.03 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $13.27 | 1 | $0 (2020) |
| Mylan Specialty L.P. | $12.27 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.36 | 13 | GlaxoSmithKline, LLC. ($148.97) |
| 2023 | $32.58 | 2 | GlaxoSmithKline, LLC. ($32.58) |
| 2022 | $34.83 | 2 | ABBVIE INC. ($17.80) |
| 2021 | $12.27 | 1 | Mylan Specialty L.P. ($12.27) |
| 2020 | $13.27 | 1 | SANOFI-AVENTIS U.S. LLC ($13.27) |
| 2019 | $20.96 | 1 | Teva Pharmaceuticals USA, Inc. ($20.96) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: VACCINES | ||||||
| 06/14/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 05/25/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/30/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/12/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Endocrinology | ||||||
| 10/30/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 79 | $6,140 | $3,565 |
| 2022 | 2 | 43 | 71 | $6,066 | $3,066 |
| 2021 | 2 | 27 | 59 | $4,524 | $2,137 |
| 2020 | 1 | 27 | 59 | $4,366 | $1,655 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 55 | $3,740 | $2,278 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 24 | $2,400 | $1,287 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 35 | $3,500 | $1,639 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 36 | $2,566 | $1,427 | 55.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 43 | $2,924 | $1,408 | 48.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 16 | $1,600 | $728.55 | 45.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 59 | $4,366 | $1,655 | 37.9% |
About Dr. John Holston, MD
Dr. John Holston, MD is a Internal Medicine healthcare provider based in Searcy, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881658623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Holston, MD has received a total of $280.27 in payments from pharmaceutical and medical device companies, with $166.36 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($280.27).
As a Medicare-enrolled provider, Holston has provided services to 138 Medicare beneficiaries, totaling 268 services with total Medicare billing of $10,422. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Searcy, AR
- Active Since 04/17/2006
- Last Updated 11/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881658623
Products in Payments
- TRELEGY ELLIPTA (Drug) $162.36
- AJOVY (Drug) $20.96
- SHINGRIX (Biological) $19.19
- DALVANCE (Drug) $17.80
- VOQUEZNA (Drug) $17.39
- Ozempic (Drug) $17.03
- SOLIQUA 100/33 (Biological) $13.27
- Yupelri (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Searcy
David Johnson, Md, MD
Internal Medicine — Payments: $8,776
Reid Thomas, Md, MD
Internal Medicine — Payments: $8,116
Steven Fincher, Md, MD
Internal Medicine — Payments: $6,103
Jyoti Chaudhary, M.d, M.D
Internal Medicine — Payments: $5,325
Eric Robinson, Md, MD
Internal Medicine — Payments: $3,513
Dr. Robert Camferdam, M.d, M.D
Internal Medicine — Payments: $1,405